| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |